BridgeMD
SAFEST
EU CTIS ID: 2022-502059-79-00
What this study is testing
To assess whether daily functioning and health related quality of life are better at two years when statins are stopped or not initiated, compared to when statins are used, in frail patients of >= 70 years with a recent ischemic stroke or transient ischemic attack.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age = 70 years or older at the time of ischemic stroke or TIA; inclusion within 6 weeks after diagnosis of ischemic stroke or TIA; frailty as defined by a pre-event score of 4-7 and/or post-event score of 6-7 on the validated Clinical Frailty Scale.
You likely can't join if
- Very severe frailty or very limited life expectancy (< 6 months) as defined by a score >= 8 points on the validated Clinical Frailty Scale; a previous serious adverse drug reaction to statins; not speaking Dutch; being unable to answer questions and have no proxy assessment available; being unable or not willing to give written informed consent (either patient or patient with help from proxy).
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.